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Intracellular Antibody
Neutralizes Listeria Growth
et al., 1996). Antibody opsonization of Listeria provides
no increased host resistance (Mackaness, 1962; Miki
and Mackaness, 1964). Therefore, we reasoned that
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Department of Pathology and Immunology
Washington University School of Medicine
660 South Euclid Avenue, Box 8118 anti-LLO antibody-mediated protection was occurring
through a novel mechanism, distinct from the classicalSt. Louis, Missouri 63110
mechanism of enhanced macrophage phagocytosis of
antibody-opsonized extracellular bacteria. One poten-
tial mechanism whereby antibody to LLO could provideSummary
protection against infection would be through the intra-
cellular neutralization of LLO within phagocytic cells (aWe previously reported that treatment of mice with a
neutralizing mAb against listeriolysin O (LLO), the hypothesis first put forward by Casadevall [1998]). Neu-
tralization of LLO would block Listeria escape to thepore-forming toxin of Listeria monocytogenes, pro-
vided resistance to this intracellular bacterium. We host cell cytosol and thereby block the rapid bacterial
replication which takes place at this site. Consistent withevaluated whether anti-LLO mAb would affect Listeria
handling by macrophages, essential cells in Listeria this hypothesis is the fact that mutant Listeria unable to
secrete LLO are virtually avirulent in vivo, do not reachresistance. Macrophages infected in the presence of
anti-LLO mAb showed a marked reduction in intracel- the host cell cytosol, and are rapidly killed within phago-
lysosomes of macrophages (Portnoy et al., 1988). Here,lular Listeria growth, with a concomitant block in LLO-
dependent Listeria passage from phagosome to cyto- we describe experiments aimed at testing this hypothe-
sis, utilizing resting murine peritoneal macrophages andsol. Anti-LLO mAb did not opsonize Listeria but, rather,
acted within macrophages to neutralize LLO. Impor- mouse anti-LLO mAb. Our results indicate that indeed
antibody can act intracellularly to neutralize a secretedtantly, anti-LLO mAb effects on Listeria growth were
independent of Fcg receptor expression, IFNg signal- Listeria virulence factor, having profound implications
on the role of antibody to intracellular microbial patho-ing, and production of nitric oxide and superoxide.
These results identify a novel mechanism for antibody gens in general. We provide evidence that this mecha-
nism of protection also operates in vivo and may becontrol of bacteria within macrophages.
responsible for our previous results.
Introduction
Listeria monocytogenes is a Gram-positive, facultative Results
intracellular bacterium that has served as a model for
understanding host resistance to infection. Early resis- Antibody to LLO Limits Listeria Growth
within Macrophagestance is controlled by the innate immune response, such
that neutrophils and macrophages largely control the To assess the effect of anti-LLO mAb on macrophage
handling of Listeria, we measured intracellular Listeriainitial phases of infection (Unanue, 1997). Antigen-spe-
cific T cells are then primed and activated over 4-6 days, growth in resident peritoneal macrophages. Cells were
incubated ex vivo with the antibody, subsequently in-resulting in the rapid clearance of all Listeria and the
establishment of immunological memory (Busch et al., fected with Listeria, and then treated with gentamicin
at a concentration sufficient to kill only extracellular or-1998, 1999). Antibody had long been thought to play no
role in Listeria resistance, since early studies transfer- ganisms but having no effect on intracellular bacterial
growth. The neutralizing A4-8 anti-LLO mAb caused aring serum from Listeria-immune mice to naive mice
showed no ability to provide protection (Osebold and marked reduction in Listeria number within macro-
phages during the first 2 hr of infection (2- to 5-fold inSawyer, 1957; Mackaness, 1962; Miki and Mackaness,
1964). Recently, we reported the surprising finding that four experiments), followed by the subsequent rapid
a neutralizing mAb to LLO, the secreted Listeria pore- replication of the organism within the cells (Figure 1A).
forming toxin mediating bacterial escape to the host A control mAb or E4-3, a nonneutralizing anti-LLO mAb,
cell cytosol (Gaillard et al., 1987; Portnoy et al., 1988), revealed no reduction in Listeria number during the first
provided resistance to Listeria infection (Edelson et al., 2 hr of infection. At 6 hr postinfection, typically 5- to
1999). Antibody-mediated protection required neutral- 10-fold fewer bacteria were present within the macro-
ization of LLO, as a nonneutralizing mAb specific for phages treated with A4-8, a reduction in Listeria number
LLO did not provide resistance. Antibody-mediated pro- similar to that found in macrophages activated by in
tection was evident very early (within 6 hr) after infection vitro treatment with the cytokine IFNg prior to infection
and occurred in SCID mice, indicating that the effects (Figure 1B). Moreover, combined treatment with IFNg
of antibody were independent of the adaptive immune and A4-8 was synergistic, causing a marked reduction
response. in Listeria colony-forming units (CFU) greater than that
Listeria adhere to and are readily phagocytosed by provided by cytokine or antibody alone.
macrophages in an opsonin-independent fashion (Pierce This pattern of Listeria growth in macrophages treated
with neutralizing anti-LLO mAb is most consistent with
an antibody-mediated interference in the passage of1Correspondence: unanue@pathbox.wustl.edu
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Figure 1. Neutralizing Anti-LLO Antibody Limits Intracellular Listeria Growth within Macrophages
(A) Resident peritoneal macrophages from SCID mice were treated in vitro with 10 mg/ml control mAb, E4-3 anti-LLO nonneutralizing mAb,
or A4-8 anti-LLO neutralizing mAb and were infected with Listeria EGD. CFU per coverslip were evaluated at the indicated times (mean 6
SEM).
(B) Resident peritoneal macrophages from SCID mice were treated in vitro with or without IFNg (100 U/ml) and with control or A4-8 mAb (100
mg/ml) and were infected with Listeria EGD. CFU per coverslip were evaluated at 6 hr postinfection (mean 6 SEM).
Listeria from phagosome to cytosol, allowing the macro- No reduction in Listeria growth took place when or-
ganisms were first incubated with the A4-8 mAb andphage to carry out listericidal mechanisms on those
bacteria forced to remain in the phagosome. Those Lis- washed prior to infection of the macrophages (Figure
2A), confirming that the A4-8 antibody was not actingteria managing to reach the cytosol (a smaller number
than in control cells) would still be able to divide in an as an opsonin. A4-8 treatment of macrophages from
mice deficient in either the Fcg activating receptorsuncontrolled manner within this host compartment, at
a rate similar to the cytosolic bacteria in control cells. FcgRI and FcgRIII (Fc g chain-deficient mice) or the
inhibitory receptor FcgRII caused a reduction of ListeriaThese ideas will be explicitly addressed in experiments
below. growth indistinguishable from the treatment of control
Figure 2. Anti-LLO Neither Opsonizes Listeria Nor Requires Fcg Receptor Expression for Function in Macrophages
(A) Listeria EGD were incubated overnight with various concentrations of control mAb, A4-8 mAb, or buffer alone (0), washed, and then were
used to infect resident peritoneal macrophages from SCID mice. CFU per coverslip were evaluated at 6 hr postinfection (mean 6 SEM).
(B) Resident peritoneal macrophages from CB.17, Fc g chain-deficient, or FcgRII-deficient mice were treated in vitro with control or A4-8 mAb
(100 mg/ml) and were infected with Listeria EGD. CFU per coverslip were evaluated at 6 hr postinfection (mean 6 SEM).
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smaller absolute number of organisms were present
within A4-8-treated cells (for example, control cells: av-
erage of 5 bacteria/cell, 3 of 5 cytosolic; A4-8-treated:
average of 2.6 bacteria/cell, 0.4 of 2.6 cytosolic). Treat-
ment with neutralizing anti-LLO mAb, therefore, partially
blocks Listeria escape to the cytosol and has a marked
effect on limiting Listeria numbers within the macro-
phages.
Antibody Acts Intracellularly to Block
LLO within Macrophages
We examined whether the A4-8 antibody could act
within macrophages to neutralize LLO. Macrophages
were incubated overnight with mAb prior to infection,
extensively washed, and subsequently infected with Lis-
teria organisms. Treatment with the A4-8 mAb in this
protocol still resulted in a marked control of Listeria
growth within macrophages (Figure 4A), although to a
lesser degree than when antibody was present both
before and during infection. To determine the effective
life span of anti-LLO molecules within macrophages,
cells were treated with mAb overnight, then washed
extensively, and incubated for 0, 4, or 8 hr in the absence
of mAb (so-called “chase”; Figure 4B). Cells were then
infected with Listeria, and intracellular bacterial growth
was measured. Anti-LLO mAb had significantly less ef-
fect on bacterial growth if chased for 4 or 8 hr, sug-
gesting proteolytic breakdown of the antibody within
the macrophages.
A4-8 molecules were seen in discrete vesicles through-
out the macrophages and could be colocalized with
Listeria-containing vacuoles by confocal microscopy
(Figure 5). These Listeria were confirmed to be in phago-
somes, as they did not stain with phalloidin. Antibody
Figure 3. Anti-LLO Blocks Listeria Escape to the Cytosol within molecules could also be found in vesicles of macro-
Macrophages phages treated with antibody prior to infection. In these
(A–D) Resident peritoneal macrophages from SCID mice were cases, the macrophages were washed and infected for
treated in vitro with 10 or 100 mg/ml control mAb ([A and B], showing 2 hr in the absence of mAb. Control antibody-treatedthe same two cells in each panel) or A4-8 mAb ([C and D], showing
cells also showed intracellular antibody-containing vesi-the same two cells in each panel) and were infected with Listeria
cles that sometimes colocalized with Listeria-containingEGD. At 2 hr postinfection, cells were stained with rabbit anti-Listeria
polyserum followed by FITC goat anti-rabbit IgG to identify all Liste- vacuoles, although many more bacteria in these cells
ria organisms, regardless of intracellular location (A and C), and were cytosolic.
with Alexa 594 phalloidin to identify cytosolic Listeria (B and D). To precisely determine the amount of A4-8 antibody
Note in control mAb-treated cells (A and B) that the majority of taken up by the macrophages through fluid-phase endo-bacteria are double stained, indicating their cytosolic location, while,
cytosis, we incubated macrophages overnight with 100in the anti-LLO-treated cells (C and D), most bacteria are not staining
mg/ml A4-8, washed the cells extensively, and thenwith phalloidin, indicating their phagosomal location.
(E) Listeria were scored as either cytosolic or phagosomal (see made cell lysates. The amount of A4-8 contained within
Experimental Procedures). Each point represents a randomly se- the lysates was quantitated through use of an ELISA
lected high-power field of view, in which the bacteria contained assay with plate-bound, pure recombinant histidine-
within the central 12 macrophages were evaluated (z30 to 50 bacte- tagged LLO (see Experimental Procedures). The lysateria per field).
of 3.88 3 105 cells contained a total of 4.95 ng A4-8,
equivalent to z5 3 104 functional antibody molecules/
macrophage.macrophages. These results rule out an absolute require-
ment for these receptors in antibody action (Figure 2B).
Requirements for IFNg Signaling, RNI,
and ROI during Anti-LLO ActionAntibody to LLO Blocks Listeria Escape
to the Cytosol A4-8 mAb affected Listeria handling without activation
of the macrophages. A4-8 treatment dramatically limitedBy direct microscopy, A4-8 treatment had two effects
on Listeria within the macrophages. First, a significantly Listeria growth within peritoneal macrophages from
mice deficient in either the IFNg receptor or the STATsmaller percentage of the total bacteria were cytosolic in
A4-8-treated cells (Figure 3; z60% cytosolic for control 1 molecule, the transcription factor mediating IFNg sig-
naling (Figures 6A–6C). However, in these signaling-defi-cells versus 15% cytosolic for A4-8-treated cells). Sec-
ond, in accordance with the Listeria CFU assays, a cient macrophages, in vitro treatment with IFNg or the
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Figure 4. Anti-LLO Functions Intracellularly within Macrophages to Limit Listeria Growth
(A) Resident peritoneal macrophages from SCID mice were treated in vitro with control or A4-8 mAb (100 mg/ml) and were infected with
Listeria EGD. Antibody was present in the culture, either at all stages of the experiment (overnight preinfection, during infection, and during
the time of gentamicin treatment) or just at specified times. CFU per coverslip were evaluated at 6 hr postinfection (mean 6 SEM).
(B) Resident peritoneal macrophages from SCID mice were treated in vitro with control or A4-8 mAb (10 mg/ml) and were infected with Listeria
EGD. Antibody was present in the culture, either at all stages of the experiment (“throughout”) or cells were washed and then chased in media
in the absence of mAb for the indicated time period prior to infection. CFU per coverslip were evaluated at 6 hr postinfection (mean 6 SEM).
combination of IFNg and TNFa had no ability to induce intracellular replication of bacteria in these cells was
followed. The growth of Listeria in cells from micelistericidal activity. Thus, the effect of the A4-8 mAb in
no way requires IFNg-mediated macrophage activation. treated with the anti-LLO mAb was markedly less than
in cells from mice treated with control mAb (Figure 7).We performed experiments in which antibody-treated
macrophages were also treated with the iNOS inhibitor In fact, the pattern of growth was similar to that seen
in our ex vivo infection system (Figure 1A), where a largeaminoguanidine hemisulfate and/or the cell-permeable
superoxide scavenging molecule MnTMPyP. Anti-LLO number of bacteria were killed during the first 2 hr of
infection, with subsequent growth of those organismstreatment in the presence of these chemicals still led to
marked control of Listeria replication, indicating that that had managed to escape to the cytosol.
macrophages utilize mechanisms other than RNI or ROI
to control Listeria growth (Figure 6D). To confirm our
Discussiondata with MnTMPyP, we also utilized macrophages from
mice deficient in the gp91 subunit of the NADPH oxidase
Antibody-Mediated Listeria Resistanceand again confirmed the presence of RNI- and ROI-
This report demonstrates that neutralization of LLO byindependent killing mechanisms (Figure 6E).
a mAb occurred intracellularly within resting macro-To further explore this issue of RNI- and ROI-indepen-
phages and that this neutralization resulted in the limita-dent Listeria killing, we compared Listeria growth in
tion of Listeria growth. This process was not mediatedmacrophages infected with wild-type Listeria (10403S)
by Listeria opsonization nor required Fcg receptor liga-or a mutant strain deleted for LLO (EJL1) (Figure 6F).
tion. Antibody molecules were taken into macrophagesThis strain of Listeria is completely retained within mac-
through fluid phase endocytosis and could traffic withinrophage phagosomes (data not shown). Therefore, use
endosomal compartments of the cell to encounter Liste-of EJL1 provided a second method to confirm our results
ria-containing vacuoles. This encounter resulted in Lis-regarding radical-independent killing of phagosome-
teria retention within phagosomes, akin to what occursretained organisms, which we demonstrated above
for Listeria organisms deficient in LLO production. Re-through the use of anti-LLO mAb-mediated blockade of
tention in the phagosome resulted in the demise of theListeria escape to the cytosol. Macrophages efficiently
organism through mechanisms that did not require thecontrolled the growth of the EJL1 strain, independent
participation of RNI or ROI.of cytokine activation, RNI, and ROI.
Macrophage uptake of soluble proteins from solution
is known to occur at a rate proportional to their concen-
tration in the culture medium and serves as one mecha-Anti-LLO Action within Macrophages Occurs In Vivo
To determine whether anti-LLO-mediated Listeria resis- nism whereby macrophages acquire proteins to be pre-
sented by MHC class II molecules. Incubation in 0.7tance in vivo (Edelson et al., 1999) also occurs within
macrophages, we performed the following experiment. mM mAb (100 mg/ml) resulted in z5 3 104 molecules/
macrophage, an estimation very much consistent withSCID mice were treated with 1 mg mAb i.p. and 3 days
later infected with 1 3 106 Listeria i.p. Infected peritoneal that found for the fluid phase uptake of soluble HRP
(Steinman and Cohn, 1972). This number of intracellularmacrophages were collected 1 hr postinfection, and the
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Figure 5. Anti-LLO-Containing Vesicles Co-
localize with Listeria-Containing Vacuoles
within Macrophages
Resident peritoneal macrophages from SCID
mice were treated in vitro with A4-8 mAb (100
mg/ml) and were infected with Listeria EGD.
At 2 hr postinfection, cells were stained with
(A) rabbit anti-Listeria polyserum followed by
Cy5 goat anti-rabbit IgG (blue), (B) Alexa 488
phalloidin (green), and (C) Cy3 goat anti-
mouse IgG (red) to identify Listeria- and mAb-
containing vesicles and were examined by
confocal microscopy. (D) Represents the tri-
ple overlay of the images, with (E) and (F)
being higher-power views of particular areas
of the image in (D). Numbers in the left corner
denote length in microns. Note that all Listeria
(seven organisms in total) are contained
within phagosomes, based on their negative
staining with phalloidin. In (E) and (F), anti-
body-containing vesicles can be seen colo-
calizing with Listeria-containing vacuoles.
anti-LLO mAb molecules is sufficient to neutralize the This protection was evident very early (a 10-fold reduc-
tion in Listeria burden was seen as early as 6 hr postin-relatively small amount of LLO thought to be produced
by Listeria (measured to be one molecule per minute fection) and by 2 days postinfection was very marked
(2–3 log reduction in Listeria CFU in spleen and liver).per bacterium; Villanueva et al., 1995). Based on our
pulse-chase experiment (Figure 4B), we estimate that During the first 2 days of Listeria infection in vivo, macro-
phages become activated via the action of cytokines,the half-life of functional A4-8 antibody within resting
macrophages was 2–4 hr, consistent with a previous including IFNg. Our ex vivo results show a synergy be-
tween anti-LLO mAb and IFNg activation of macro-measurement of the half-life of 125I-IgG within murine
macrophages (t1/2 5 2.6 hr; Mellman et al., 1983). phages, possibly explaining the significant reduction in
Listeria CFU seen in vivo at 2 days postinfection afterThe concentration of antibody used in our ex vivo
experiments is easily reached by the in vivo injection of anti-LLO mAb treatment.
In addition to the intracellular neutralization of LLOA4-8, which 1 day after a 1 mg injection has a serum
concentration of z300 mg/ml (data not shown). Indeed, within macrophages, anti-LLO mAb may also provide
resistance in vivo through neutralization of the exotoxinmacrophages harvested as long as 3 days after anti-
LLO mAb injection in vivo controlled Listeria infection activities of LLO (Guzman et al., 1996; Kayal et al., 1999;
Merrick et al., 1997; Nishibori et al., 1996; Sibelius et al.,ex vivo. This finding supports our contention that one
locus of action of the antibody in the mouse is by a 1996, 1999; Tang et al., 1996; Wadsworth and Goldfine,
1999). We have previously documented a role for extra-mechanism akin to what we have found ex vivo. In vivo,
there was a significant reduction in organ Listeria burden cellular LLO in the induction of lymphocyte apoptosis
during early Listeria infection (Merrick et al., 1997), andin mice treated with anti-LLO mAb (Edelson et al., 1999).
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Figure 6. Anti-LLO Antibody Limits Intracellular Listeria Growth Independent of IFNg Signaling, RNI, and ROI
(A–C) Resident peritoneal macrophages from (A) 129 Sv/Ev, (B) IFNg receptor-deficient, and (C) STAT 1-deficient mice were treated in vitro
with either 100 mg/ml control, A4-8 mAb, or with TNFa (1000 U/ml) and/or IFNg (100 or 1000 U/ml). Cells were infected with Listeria EGD, and
CFU per coverslip were evaluated at 6 hr postinfection (mean 6 SEM).
(D) Resident peritoneal macrophages from SCID mice were treated in vitro with 100 mg/ml control or A4-8 mAb in the presence of aminoguanidine
hemisulfate (AG; 1 mM) and/or MnTMPyP (100 mM). Cells were infected with Listeria EGD, and CFU per coverslip were evaluated at 6 hr
postinfection (mean 6 SEM).
(E) Resident peritoneal macrophages from C57BL/6J (WT) or NADPH oxidase-deficient mice were treated in vitro with 100 mg/ml control or
A4-8 mAb either with or without aminoguanidine hemisulfate (AG; 1 mM). Cells were infected with Listeria EGD, and CFU per coverslip were
evaluated at 6 hr postinfection (mean 6 SEM).
(F) Resident peritoneal macrophages from SCID mice were treated in vitro with or without IFNg (100 U/ml) and with or without the combination
of aminoguanidine hemisulfate (AG; 1 mM) and MnTMPyP (100 mM). Cells were infected with either wild-type LLO-producing Listeria 10403S
or LLO-deficient Listeria EJL1. CFU per coverslip were evaluated at 6 hr postinfection (mean 6 SEM).
in preliminary experiments with anti-LLO mAb we have infection (Bomsel et al., 1998; Burns et al., 1996; Gollins
and Porterfield, 1986; Levine et al., 1991; Mazanec etseen a significant decrease in the extent of lymphocyte
apoptosis within the spleen at 48 hr postinfection (data al., 1992, 1995; Virgin et al., 1994). IgA and IgM molecules
were shown to neutralize viral replication within or viralnot shown). This effect may be a direct one of neutraliza-
tion of extracellular LLO or an indirect one as a result transcytosis across epithelial cells. In these studies, an-
tibody applied to the basolateral surface was trans-of the mechanism described here (i.e., intracellular neu-
tralization limiting Listeria growth). Regardless, how the ported through cells via the polymeric Ig receptor, and
virus was applied on the apical surface. Antibody andsevere lymphocyte apoptosis plays a role in Listeria
resistance is unclear at this time. virus were seen to colocalize within endosomes, re-
sulting in a restriction in viral titer and a recycling ofOur data with anti-LLO mAb represents a striking ex-
ample of intracellular antibody neutralizing a secreted antibody-virus complexes to the apical surface. Other
mechanisms have been shown to exist for IgG-mediatedbacterial virulence factor, resulting in the inhibition of
bacterial replication. However, there are precedents in intracellular viral neutralization, involving either antibody
inhibition of intraendosomal proteolytic viral uncoatingviral resistance for the ability of antibody molecules to
neutralize viral replication intracellularly and, in some or inhibition of intraendosomal fusion of the viral enve-
lope with the endosomal membrane.cases, to also provide in vivo protection against viral
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oligonucleotide depletion of the GTPase rab5a blocks
killing of LLO-deficient Listeria (Alvarez-Dominguez and
Stahl, 1999). Our results with anti-LLO antibody fit well
with this model, such that antibody-mediated phago-
some retention of Listeria allows for greater opportunity
for phagosome-lysosome fusion, such that subsequent
bacterial killing can take place.
We interpret our results on the role of IFNg as one
regulating vesicular traffic and separate from the induc-
tion of RNI or ROI. Indeed, this model of Listeria traffick-
ing may explain the paradoxical findings that macro-
phage activation with IFNg works to limit cytosolic
escape and enhance the killing of wild-type Listeria yet
induces little enhancement in the already efficient killing
of LLO-deficient organisms (Figure 6F; Portnoy et al.,
1989). For the case of wild-type Listeria, if IFNg treat-
Figure 7. Anti-LLO Antibody Acts In Vivo within Macrophages ment were to simply enhance the overall rate of phago-
CB.17-SCID mice were treated with 1 mg control or anti-LLO mAb some-lysosome fusion, the time period of Listeria exis-
and 3 days later were infected with 1 3 106 Listeria EGD i.p. At 1
tence in the primary phagosome would be limited, andhr postinfection, peritoneal macrophages were collected, and the
the number of organisms delivered to the phagolyso-intracellular growth of Listeria was followed. CFU per coverslip were
some for killing would be increased. For the case ofevaluated at 0, 2, 4, and 6 hr. At time 0, control CFU per coverslip
were 1.42 3 103 6 2.39 3 102, and anti-LLO CFU per coverslip were LLO-deficient Listeria, all organisms are delivered to the
2.05 3 103 6 4.08 3 101. Listeria growth is represented as the phagolysosome, independent of the speed of traffick-
percent relative to time 0. Within control macrophages, Listeria num- ing, such that the cytokine would not enhance bacterial
ber remained constant during the first 2 hr of infection, with bacteria
killing. Two studies have provided support for this ideacompleting almost three cell divisions between times 2 and 6 hr of
of IFNg-mediated enhancement of phagosome-lyso-infection. Within macrophages from mice treated with anti-LLO,
approximately half of all bacteria were killed during the first 2 hr of some fusion in macrophages (Alvarez-Dominguez and
infection, after which time the bacterial replication rate was similar Stahl, 1998; Via et al., 1998).
to that in control cells. Regarding the role of RNI and ROI in Listeria killing
by resident peritoneal macrophages, we found essen-
tially no role for RNI and only a limited role for ROI.
Macrophage Control of Listeria Growth These results are largely consistent with the work of
Over the past decade, several studies examined the other investigators, with differences likely due to either
mechanisms of Listeria killing by macrophages (Alvarez- the particular cell type used or the assessment of Listeria
Dominguez and Stahl, 1999; Beckerman et al., 1993; de
CFU at other time points. The identification of constitu-
Chastellier and Berche, 1994; Fehr et al., 1997; Fleming
tive bacterial killing mechanisms present in macrophage
and Campbell, 1997; Frei et al., 1993; Higginbotham et
phagolysosomes which do not involve RNI or ROI is an
al., 1992; Inoue et al., 1995; Leenen et al., 1994; Muller
important future goal.et al., 1999; Ohya et al., 1998a, 1998b; Portnoy et al.,
In conclusion, our data with anti-LLO mAb identify a1989; Shiloh et al., 1999; Tanaka et al., 1995). Experimen-
novel mechanism for intracellular antibody control oftal protocols have varied considerably and have resulted
bacteria within macrophages and show the potentialin different conclusions on how macrophages kill Liste-
for new vaccine strategies aimed at inducing antibodyria, particularly with regard to the role of RNI and ROI
responses to virulence factors of intracellular microbialin killing.
pathogens.Here, we attempt to consolidate these disparate find-
ings into a coherent picture of how macrophages handle
Listeria, in light of our results here with anti-LLO mAb. Experimental Procedures
Upon initial infection, Listeria organisms are contained
Micewithin primary phagosomes. Some organisms escape
CB.17, CB.17-SCID, Fc receptor g chain-deficient (Balb/c back-from this compartment to the cytosol via the action of
ground), FcgRII-deficient (Balb/c background), 129 Sv/Ev, IFNg re-LLO, prior to phagosome-lysosome fusion. After this
ceptor-deficient (129 Sv/Ev background), STAT 1-deficient (129 Sv/fusion event, organisms which have not yet reached the
Ev background), C57BL/6J, and NADPH oxidase-deficient (gp91phox,
cytosol will be killed. Evidence for this model comes C57BL/6J background) mice were maintained and bred under SPF
from an electron microscopic study of Listeria infection, conditions in the Washington University mouse facility (Huang et
which identified the lysosomal enzyme acid phospha- al., 1993; Meraz et al., 1996; Pollock et al., 1995; Takai et al., 1994;
Takai et al., 1996). Fc receptor-deficient mice were a gift of Dr.tase within the compartment of Listeria killing (de
Jeffrey Ravetch, Rockefeller University, New York, NY. 129 Sv/Ev,Chastellier and Berche, 1994). This report suggested a
IFNg receptor-deficient, and STAT 1-deficient mice were a gift of“competition” between the efficiency of Listeria traffick-
Dr. Robert Schreiber, Washington University, St. Louis, MO. NADPHing to this lysosomal compartment, where killing is be-
oxidase-deficient mice were a gift of Dr. Mary Dinauer, Indiana Uni-
lieved to occur, and the speed and capacity of Listeria versity School of Medicine, Indianapolis, IN. C57BL/6J mice were
to escape from the primary phagosome. A second piece obtained from the Jackson Laboratory, Bar Harbor, ME. Macro-
of evidence for this model comes from a study showing phages were obtained from mice of either sex, between ages 8 and
20 weeks.that blockade of phagolysosome fusion by antisense
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Bacteria 2 3 109 bacteria were washed in PBS and were incubated in 1 ml
mAb solution in PBS (mAb concentrations ranged from 1 mg/ml to 1Listeria monocytogenes strains used in this study were the follow-
ing: the wild-type strain EGD, the LLO deletion mutant EJL1, and mg/ml). Bacteria and antibody were rotated overnight at 48C, washed
three times with PBS, and bacterial concentration was redeterminedthe wild-type parent strain of EJL1, 10403S. EJL1 and 10403S were
a gift of Dr. Hao Shen, University of Pennsylvania, Philadelphia, PA. by OD560. This bacteria was then diluted and used for infection of
macrophages.Bacteria was stored as frozen glycerol stocks at –808C. For ex vivo
infection of macrophages, overnight cultures of Listeria were grown At various time points postinfection, coverslips (each condition
was assayed in triplicate) were taken to assess CFU/coverslip. Cov-in BHI liquid media (Becton Dickinson; Cockeysville, MD) at 378C
without agitation. Listeria concentration was estimated from a stan- erslips were dipped five times in warm PBS, then placed into 10 ml
cold sterile deionized water, vortexed for 30 s to lyse cells, anddard curve at OD560. Listeria was diluted into DMEM (GIBCO-BRL;
Grand Island, NY) 1 10% heat-inactivated FCS (Hyclone; Logan, serial dilutions of lysates were plated on BHI-agar plates. Bacterial
colonies were counted after overnight growth at 378C.UT) (no antibiotics added) immediately prior to infection of macro-
phages.
Quantitation of Antibody Uptake by Macrophages
Macrophages from CB.17-SCID mice were incubated with eitherAntibodies
mAbs utilized in this study were A4-8 (murine anti-LLO, IgG1), E4-3 control mAb or A4-8 (100 mg/ml), as described for the infection
experiments. After 22 hr, total cell number per coverslip was deter-(murine anti-LLO, IgG1), and the irrelevant control GIR.208 (murine
anti-human IFNg receptor, IgG1, a gift of Dr. Robert Schreiber, mined by the counting of cells in 12 high-power (4003) fields of
view. The area per field of view was determined by use of a slideWashington University, St. Louis, MO). The generation and proper-
ties of anti-LLO mAbs A4-8 and E4-3 were described previously micrometer, allowing an assessment of the average cell number per
field of view and therefore the cell number per coverslip. Coverslips(Nato et al., 1991). Neutralizing A4-8 binds LLO in ELISA assays and
blocks LLO-mediated lysis of RBC in vitro. Nonneutralizing E4-3 were gently dipped in warm PBS a total of 20 times to remove
extracellular antibody and then were placed into fresh wells of abinds LLO in ELISA assays but does not block RBC lysis by LLO in
vitro. mAbs were purified from ascites using standard methods on 24-well plate. Cells from 12 coverslips (z4 3 105 cells total) were
lysed in a total volume of 300 ml lysis buffer (PBS plus 40 mMprotein A-Sepharose (Sigma Chemical Company; St. Louis, MO) and
contained less than ten endotoxin units per milligram protein by N-methyl-N-octanoyl-D-glucamine, 40 mM N-methyl-N-nonanoyl-
D-glucamine, 1mM PMSF, 10 mM iodoacetamide, and 20 mg/ml leu-the QCL-1000 endotoxin quantitation kit (BioWhittaker, Walkersville,
MD). Antibody concentration was determined by absorbance at peptin) by vigorous pipetting, and lysate was subsequently centri-
fuged at 12,000 3 g for 5 min. Control coverslips without cells wereOD280 (1 mg/ml equals 1.35 absorbance units).
treated in an identical fashion.
To determine the amount of A4-8 mAb in these lysates, an ELISAEx Vivo Listeria Infection of Macrophages
assay was performed with plate-bound histidine-tagged recombi-Resident peritoneal exudate cells (PEC) were obtained by peritoneal
nant LLO (HisLLO; produced in E. coli, a gift of Dr. Daniel Portnoy,lavage and plated in DMEM 1 10% heat-inactivated FCS supple-
University of California, Berkeley, CA [Gedde et al., 2000]). Thismented with 50 U/ml penicillin and 50 mg/ml streptomycin (complete
assay has been described previously and was only modified heremedia) on 12 mm glass coverslips (Fisher Scientific, Pittsburgh, PA)
by coating the plates with a greater amount of HisLLO (500 ng/well)in 24-well plates (Costar, Corning, NY). PEC were plated at 5 3 105
to allow more sensitive detection of antibody (Edelson et al., 1999).cells per well in a volume of 1 ml and were incubated at 378C for
Cell lysate (100 ml) was used as primary antibody in the assay,2–4 hr. Coverslips were dipped five times in warm complete media
followed by secondary goat anti-mouse IgG-peroxidase (Boeh-to remove nonadherent cells and were placed in new 24-well plates.
ringer-Mannheim, Indianapolis, IN). Plates were then treated withThe remaining cells were typical adherent macrophages. Cells were
1 mM ABTS in citrate buffer with 0.05% H2O2, and OD415 wascultured 24 hr in complete media and then washed three times in
measured. Absorbance values were compared to a standard curveantibiotic-free complete media before the addition of mAbs.
made by performing the ELISA with dilutions of the A4-8 mAb inFor experiments in which macrophages were treated with mAbs,
lysis buffer. The assay allowed the reliable detection of between 1cells were cultured an additional 16 hr in the presence of 10 mg/ml
and 1000 nanograms of A4-8.or 100 mg/ml mAb in antibiotic-free media prior to infection. This
media was removed from coverslips, and 1 3 105 Listeria, with or
without fresh mAb, was added to each well. Plates were centrifuged Immunofluorescent Localization of Listeria and mAb
within Macrophagesat 600 3 g for 10 min at room temperature to synchronize the
infection of cells and then were incubated at 378C for 15 min (time Antibodies and reagents used for staining were as follows: rabbit
anti-Listeria polyserum (serotypes 1 and 4, used at 1/200 dilution;0). After an additional 15 minutes at 378C, media was again aspirated
and changed to media containing fresh mAb and 5 mg/ml gentamicin Difco, Detroit, MI), FITC goat anti-rabbit IgG (used at 1/200 dilution;
Sigma), Cy5 goat anti-rabbit IgG (used at 1/400 dilution; Amersham(GIBCO-BRL), capable of killing any remaining extracellular Listeria
but not capable of affecting the growth of intracellular bacteria. Pharmacia, Piscataway, NJ), Cy3 goat anti-mouse IgG (used at 1/400
dilution; Amersham Pharmacia), Alexa 488 phalloidin (used at 1/20Plates were kept at 378C during the course of the assay. For some
experiments, macrophages were pulsed with mAb for 16 hr and dilution; Molecular Probes, Eugene, OR), and Alexa 594 phalloidin
(used at 1/20 dilution; Molecular Probes).then were washed three times prior to the infection and gentamicin
steps, which were performed in the absence of mAb. In some experi- Coverslips were taken after a 2 hr Listeria infection of macro-
phages for immunofluorescent staining. All steps were carried outments, after cells were washed, they were incubated in media for
various time periods in the absence of mAb (chased) and were later at room temperature. Coverslips were washed in PBS, and cells
were fixed for 30 min in 10% buffered formalin. Coverslips wereinfected and treated with gentamicin (both in the absence of mAb).
In some experiments, macrophages were pretreated for 2 days washed again in PBS, and cells were permeabilized with Tris-buf-
fered saline (150 mM NaCl, 20 mM Tris [pH 7.4]) 1 0.1% Triton X-100in vitro with murine IFNg (100 U/ml or 1000 U/ml) or murine TNFa
(1000 U/ml, both gifts of Dr. Robert Schreiber, Washington Univer- (TBS-Tx) 1 1% BSA (GIBCO-BRL) for 15 min. Cells were stained
with rabbit anti-Listeria polyserum diluted in TBS-Tx 1 1% BSA forsity, St. Louis, MO). In other experiments, inducible nitric oxide
synthase (iNOS) was inhibited with the specific chemical inhibitor 1 hr and then washed in TBS-Tx. Secondary staining was then
performed with fluorochrome-conjugated goat anti-rabbit IgG (ei-aminoguanidine hemisulfate (Sigma), used at 1 mM, present at all
times prior to and throughout the course of the infection (Beckerman ther FITC or Cy5) and/or Cy3 goat anti-mouse IgG and fluorochrome-
conjugated phalloidin (either Alexa 488 or Alexa 594) diluted in TBS-et al., 1993; Corbett et al., 1992). Superoxide radicals were scav-
enged with the cell-permeable scavenger manganese (III) tetrakis Tx 1 1% BSA. Phalloidin staining identifies only those Listeria within
the host cell cytosol, as Listeria within this compartment are known(1-methyl-4-pyridyl) porphyrin pentachloride (MnTMPyP; Alexis, San
Diego, CA), used at 100 mM, present throughout the course of the to polymerize host cell actin on their surface (Tilney and Portnoy,
1989). Coverslips were again washed in TBS-Tx and then mountedinfection (Gardner et al., 1996; Muller et al., 1999).
To test whether mAb acted as an opsonin for Listeria organisms, in Slow Fade Light (Molecular Probes) according to manufacturer’s
Intracellular Antibody Neutralizes Listeria Growth
511
instructions. Cells were observed with either a standard Zeiss Axio- ited: antibody provides resistance to Listeria infection. J. Immunol.
163, 4087–4090.phot fluorescence microscope (Zeiss, Germany) or with a Sarastro
2000 confocal laser scanning microscope (Molecular Dynamics, Fehr, T., Schoedon, G., Odermatt, B., Holtschke, T., Schneemann, M.,
Sunnyvale, CA). Confocal images were within a single plane, with a Bachmann, M.F., Mak, T.W., Horak, I., and Zinkernagel, R.M. (1997).
thickness of z0.5 mm. Crucial role of interferon consensus sequence binding protein, but
For quantitative assessment of Listeria localization, organisms neither of interferon regulatory factor 1 nor of nitric oxide synthesis
were scored as “phagosomal” if they stained positively with anti- for protection against murine listeriosis. J. Exp. Med. 185, 921–931.
Listeria antibody but not with phalloidin. Organisms were scored as
Fleming, S.D., and Campbell, P.A. (1997). Some macrophages kill
“cytosolic” if they stained positively with both anti-Listeria antibody
Listeria monocytogenes while others do not. Immunol. Rev. 158, 69–77.
and phalloidin. Cells were observed at a magnification of 6303, count-
Frei, K., Nadal, D., Pfister, H.W., and Fontana, A. (1993). Listeria menin-ing the organisms contained within the central 12 cells per field of
gitis: identification of a cerebrospinal fluid inhibitor of macrophageview. Six randomly selected fields of view were counted per slide.
listericidal function as interleukin 10. J. Exp. Med. 178, 1255–1261.
Gaillard, J.L., Berche, P., Mounier, J., Richard, S., and Sansonetti,In Vivo mAb Treatment and Listeria Infection
P. (1987). In vitro model of penetration and intracellular growth ofCB.17-SCID mice were injected with 1 mg mAb i.p. (A4-8 or GIR.208
Listeria monocytogenes in the human enterocyte-like cell line Caco-2.control mAb) in saline. Three days later mice were infected with 1 3
Infect. Immun. 55, 2822–2829.106 Listeria EGD i.p. (diluted directly from a frozen stock into saline).
One hour later, infected PEC were collected in complete media plus Gardner, P.R., Nguyen, D.D., and White, C.W. (1996). Superoxide
5 mg/ml gentamicin (no penicillin or streptomycin). 5 3 105 cells per scavenging by Mn(II/III) tetrakis (1-methyl-4-pyridyl) porphyrin in
well were added to coverslips in a 24-well plate, and pelleted by mammalian cells. Arch. Biochem. Biophys. 325, 20–28.
centrifugation at 100 3 g for 5 min at room temperature. After 30 Gedde, M.M., Higgins, D.E., Tilney, L.G., and Portnoy, D.A. (2000).
min of adherence at 378C, this time point was taken to be time 0, Role of listeriolysin O in cell-to-cell spread of Listeria monocyto-
and CFU per coverslip were determined as described above, at genes. Infect. Immun. 68, 999–1003.
times 0, 2, 4, and 6 hr.
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